ChAd63-KH

ChAd63-KH · University of York

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ChAd63-KH, covering 2020-01-28 to 2023-05-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Safety, Efficacy and Immunogenicity of Leishmania Vaccine ChAd63-KH in PKDL [Phase 2]